DUBLIN--(BUSINESS WIRE)--The "Global Healthcare Nanotechnology (Nanomedicine) Market - Segmented by Application, Disease, Geography - Growth, Trends and Forecasts (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.
The global healthcare nanotechnology market is expected to witness a CAGR of 15.1%.
With the advantage of the properties of matter at nanoscale, nanomedicine promises to develop innovative drugs with greater efficacy and lesser side effects than standard therapies. Nanoscale objects are used by themselves or as parts of larger devices containing multiple nanoscale objects. It has the potential to change the current methods of diagnosing and treating cancer.
Translation of nano-based cancer therapies and diagnostics has witnessed significant progress and several more developments are in the pipeline. The increasing incidence of cancer and importance of nanomedicine in modern cancer treatment procedures, are expected to drive the demand for nanomedicines during the forecast period.
The other factors includes increasing incidence of cardiovascular diseases, increasing research funding and rising awareness of nanomedicine application.
Geographically, the United States currently dominates the market, and is expected to maintain its position over the forecast period. In addition to the booming R&D activities, the United States has also initiated several measures in the recent times, to advance and develop the nanotechnology applications in the healthcare sector.
Owing to the large geriatric population, growing need for diagnostics and augmented cancer therapies, government initiatives, and rising awareness of nanomedicines, the US healthcare nanotechnology sector is expected to witness a substantial growth during the forecast period.
Key Topics Covered
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)
7. Market Segmentation
8. Competitive Landscape
9. Key Players
- Abbott Laboratories
- Combimatrix Corporation
- GE Healthcare
- Sigma-Tau Pharmaceuticals Inc.
- Johnson & Johnson
- Mallinckrodt PLC
- Merck & Company Inc.
- Nanosphere Inc.
- Pfizer Inc.
- Celgene Corporation
10. Future of the Market
For more information about this report visit https://www.researchandmarkets.com/research/bwr3bj/global_healthcare?w=4